CIRS, or Chronic Inflammatory Response Syndrome, is a condition in which the body’s immune system gets stuck in a prolonged inflammatory state after exposure to biological toxins. These toxins most commonly come from water-damaged buildings but can also originate from tick-borne infections, contaminated seafood, spider bites, and certain algae. The condition produces a wide range of symptoms across multiple body systems, which is part of why it’s often misdiagnosed or missed entirely. It’s worth noting upfront that CIRS is not universally accepted in mainstream medicine. UCLA Health, for example, states that CIRS is not considered an established medical diagnosis, and almost everything about it, from diagnostic criteria to biomarkers to treatment, remains the subject of ongoing research and debate.
How CIRS Develops in the Body
The core idea behind CIRS is that certain people’s immune systems cannot properly clear biological toxins after exposure. In a healthy immune response, your body identifies a foreign substance, mounts an inflammatory attack, clears the threat, and then dials the inflammation back down. In CIRS, that last step never happens. The innate immune system, your body’s first-line, broad-spectrum defense, stays activated and keeps producing inflammatory signals long after the initial exposure has ended.
Blood work in people with CIRS typically shows a specific pattern: elevated inflammatory markers and reduced levels of regulatory neuropeptides, the chemical messengers that are supposed to calm inflammation down. One key neuropeptide called MSH (which helps regulate inflammation, hormone production, and even sleep) tends to be abnormally low. Meanwhile, at least one of several inflammatory markers tends to be elevated. This combination creates a self-perpetuating cycle where inflammation drives more inflammation, affecting the brain, gut, joints, lungs, and virtually every other system.
Why Some People Are Vulnerable
Not everyone exposed to mold or other biotoxins develops CIRS. Genetic variations in a set of immune-related genes called HLA-DR appear to play a significant role. These genes help your immune system recognize and tag foreign substances for removal. People with certain HLA-DR variations are “poor eliminators,” meaning their bodies struggle to clear mycotoxins and other biological toxins from their systems.
Research on people with these genetic variations shows that they can experience persistent mold-related symptoms long after moving out of a contaminated building, even when they’re only exposed to normal background levels of mold found in regular outdoor air. In some cases, even short periods of exposure can trigger what amounts to a chronic exposure scenario. This genetic component helps explain why one person in a household can become severely ill from a water-damaged building while everyone else feels fine.
Triggers Beyond Mold
Water-damaged buildings are the most commonly discussed trigger, but the problem isn’t just mold. A water-damaged building produces a complex mixture of hazards: fungi and fungal fragments, bacteria and bacterial fragments, volatile organic compounds, and inflammatory particulates that form what amounts to a toxic biochemical cloud in the air. Some practitioners consider actinomycetes, a type of bacteria that structurally resembles fungus, to be the most important contaminant in these environments. Endotoxins, fragments from certain bacteria, are also highly inflammatory and have been linked to broader health effects including chronic gut inflammation and neurodegenerative conditions.
Other established triggers include:
- Tick-borne infections: Lyme disease and related co-infections, including babesiosis caused by the protozoan Babesia microti
- Ciguatera: A toxin from dinoflagellate algae that accumulates in reef fish, is tasteless and odorless, and survives cooking
- Algal blooms: Exposure to water, fish, or air contaminated by Pfiesteria dinoflagellate algae
- Spider bites: Venom from brown recluse or Mediterranean recluse spiders, which triggers inflammatory cytokine release
Newer research suggests that the chronic inflammation in CIRS follows gene-level responses to endotoxins and actinomycetes, not simply exposure to these toxins. In other words, it’s the way your genes react to the exposure that determines whether you develop ongoing illness.
Symptoms Across Multiple Systems
One of the most confusing aspects of CIRS is how many different symptoms it can produce. Because the inflammation is systemic, affecting the whole body rather than one organ, people often present with a seemingly unrelated grab bag of complaints. This frequently leads to years of doctor visits and misdiagnoses before anyone considers a biotoxin-related cause.
Common symptoms include nasal congestion, sore throat, and red, watery, or itchy eyes. Respiratory symptoms range from chest tightness and wheezing to difficulty breathing. Skin irritation, rashes, and dermatitis are frequent. Headaches and fatigue are nearly universal. Beyond these, many people experience cognitive difficulties often described as “brain fog,” joint and muscle pain, sensitivity to light, unusual nerve sensations, digestive problems, mood changes, and difficulty regulating body temperature. The key clinical feature isn’t any single symptom but the presence of symptoms spanning multiple body systems simultaneously.
How CIRS Is Assessed
Because CIRS lacks universal diagnostic criteria in conventional medicine, assessment typically follows a framework developed by Dr. Ritchie Shoemaker, the physician who first described the condition. This involves documenting symptoms across multiple clusters, running specific blood tests to look for the characteristic pattern of elevated inflammatory markers and reduced regulatory neuropeptides, identifying a plausible biotoxin exposure, and ruling out other conditions.
A screening tool called the Visual Contrast Sensitivity (VCS) test is sometimes used as a preliminary step. This simple vision test measures your ability to distinguish between shades of gray at different contrast levels, which can be impaired by the neurological inflammation seen in CIRS. Proponents cite a figure suggesting that if symptoms are present and the VCS test is positive in even one eye, there’s a 98.5% probability of having CIRS. However, the test is a screening tool, not a definitive diagnosis on its own.
A small study using specialized brain MRI software called NeuroQuant examined brain volumes in 17 patients with inflammatory illness from water-damaged building exposure. Compared to 18 controls, the patients showed statistically significant differences in two brain regions: shrinkage of the caudate nucleus (involved in learning, memory, and motivation) and enlargement of the pallidum (involved in movement regulation). These structural brain changes may help explain the cognitive and neurological symptoms many people experience.
How CIRS Differs From Similar Conditions
CIRS shares significant symptom overlap with chronic fatigue syndrome (ME/CFS), fibromyalgia, and other conditions involving persistent fatigue and widespread pain. This overlap is a major reason people with CIRS often receive one of these diagnoses first.
There are some distinguishing features, though. ME/CFS tends to involve reduced activity of the stress-response system (the HPA axis), while the acute inflammatory response seen in CIRS involves heightened HPA axis activity. Gastrointestinal symptoms resembling irritable bowel syndrome are common in ME/CFS but aren’t a typical feature of the basic inflammatory response. Fever is a hallmark of acute inflammation but occurs only mildly, and in a small proportion of ME/CFS patients. Weight loss and appetite suppression, which are characteristic of an active inflammatory state, aren’t typical of ME/CFS unless depression is also present. ME/CFS also shows specific patterns of mitochondrial dysfunction, with abnormally low energy production and high lactate levels, that differ from the energy-conservation pattern seen in acute inflammatory responses.
The most practical distinguishing factor for CIRS is the exposure history. If your symptoms began or dramatically worsened after moving into a particular building, after a tick bite, or after eating reef fish, and if they span many body systems simultaneously, that exposure timeline is a critical clue that points toward a biotoxin-related process rather than ME/CFS or fibromyalgia alone.
The Controversy Around CIRS
CIRS occupies an unusual space in medicine. It has a dedicated clinical framework, published research, and practitioners who specialize in treating it, but it has not been accepted as a formal diagnosis by most mainstream medical institutions. The criteria for diagnosis, the biomarkers used, and the treatment protocols all remain subjects of debate. Many conventional physicians are unfamiliar with the condition or skeptical of its diagnostic framework.
This doesn’t mean the symptoms aren’t real. People exposed to water-damaged buildings clearly get sick, and the biological mechanisms of chronic inflammation are well-established science. The debate centers on whether CIRS, as defined by its current diagnostic criteria, represents a distinct disease entity or whether the same patients would be better served by existing diagnostic categories. For people experiencing these symptoms, the practical implication is that finding a practitioner familiar with biotoxin illness may require looking beyond a standard primary care office, and that removing yourself from the source of exposure is universally agreed upon as a necessary first step regardless of what the condition is called.